Maha Othman on 10-Year Anniversary of the CanVECTOR Research Network!
Maha Othman, Editor-in-Chief of Current Opinion in Hematology Journal, Research Co-Lead at CanVECTOR Research Network, shared on LinkedIn:
”Amazing conference this past weekend marking the 10-Year Anniversary of the CanVECTOR Research Network!
I’m truly proud to be part of the Steering Committee, Co-Leading the Basic Science and Translation Research Platform, and supporting the next generation of researchers. Congratulations to all the trainees and winners of the 2025 Platform Competition!
Special thanks to the leaders at inception — Marc Rodgers and Susan Kahn — and to the current leadership team: Grégoire Le Gal and Deborah Siegal for their continued vision and guidance.
Especially proud of two of my trainees / mentees who presented posters at the conference:
Anne F.:
“Prognostic Accuracy of the Khorana and Caprini Thromboembolic Risk Assessment Models in Patients with Gynecological Tumours: A Meta-Analysis.”
This work was made possible through the contributions of my other mentees Abdelrahman Ahmed , Zein Hammad, Omar Hajjaj, Monzer Assar, as well as key statistical insights from Queen’s University and expert input from Dr. Kerstin DeWitt
Yousra Tera
“Thromboelastography and Haematological Parameters for Venous Thromboembolism Risk Prediction in Ovarian Cancer Patients.”
This sub-study stems from our larger Women’s Cancer Thrombosis Project, completed with fantastic collaboration from Queen’s Medical Oncology and GYN Oncology teams — Drs. Anita Agrawal, Rania Chehade, George Gray — and incredible support from NP Alexandra Stewart.
Congratulations to the conference co-chairs Amye Harrigan and Jameel Abdulrehman and the entire Planning Committee for an exceptional and rich program this year.
Proud to be part of this inspiring network and looking forward to continuing our collective work advancing thrombosis research and mentorship.”
Stay updated with Hemostasis Today.
-
Jan 30, 2026, 11:38Aaron Rodriguez Calienes on Intracranial Stenting: Rescue vs First-Line Outcomes
-
Jan 30, 2026, 11:25Ahmed Nasreldein on Sex Disparities in Thrombolysis Delay Among Egyptian Stroke Patients
-
Jan 30, 2026, 11:17Yanki Yarman: My PhD Project Has Been Published in Blood!
-
Jan 30, 2026, 11:08Alexandros Apostolou on Complications Associated with IDU and Thrombophilia
-
Jan 30, 2026, 10:57Peisong Ma on GRK5 Polymorphism Affecting Platelets
-
Jan 30, 2026, 10:47Ashok Yadav Explains Fetal Thrombotic Vasculopathy: FTV
-
Jan 30, 2026, 10:34Saif ur Rahman Compares K2 and K3 EDTA: Key Differences Explained
-
Jan 30, 2026, 10:22Manpreet Gill on Heparin Resistance: When 14 Years of Experience Finally Gets a Plot Twist
-
Jan 30, 2026, 10:14Mohamed Elsaid on The Role of Hyperlipidemia in Thrombogenesis